What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Cancer
David P. Witte mainly focuses on Internal medicine, Endocrinology, Immunology, Pathology and Molecular biology.
In his study, Eosinophilia and Cohort study is inextricably linked to Gastroenterology, which falls within the broad field of Internal medicine.
His Endocrinology research is multidisciplinary, incorporating perspectives in Inclusion bodies, Ubiquitin, Lysosome and Null allele.
His Immunology research integrates issues from Andrology and Fibrinogen.
His study in the fields of Biopsy and Soft tissue under the domain of Pathology overlaps with other disciplines such as Blind study and Rhabdomyosarcoma.
His Molecular biology research includes themes of Homeobox, ROR1, Receptor tyrosine kinase and In situ hybridization.
His most cited work include:
- Absence of radius and ulna in mice lacking hoxa-11 and hoxd-11 (505 citations)
- Mutation of an axonemal dynein affects left–right asymmetry in inversus viscerum mice (472 citations)
- Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis (437 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Molecular biology, Immunology, Endocrinology and Pathology.
Many of his studies on Internal medicine apply to Gastroenterology as well.
He has researched Molecular biology in several fields, including In situ hybridization, Gene expression, Northern blot and Biochemistry.
In his study, which falls under the umbrella issue of In situ hybridization, Cell culture is strongly linked to Cell biology.
David P. Witte combines topics linked to Fibrinogen with his work on Immunology.
His Endocrinology study combines topics from a wide range of disciplines, such as Glucocerebrosidase, Receptor and Spleen.
He most often published in these fields:
- Internal medicine (32.01%)
- Molecular biology (28.06%)
- Immunology (22.30%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (32.01%)
- Pathology (19.42%)
- Immunology (22.30%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Pathology, Immunology, Biopsy and Lupus nephritis.
His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology and Oncology.
His research integrates issues of Missense mutation and Compound heterozygosity in his study of Endocrinology.
The study of Pathology is intertwined with the study of Astrogliosis in a number of ways.
His studies deal with areas such as Lung and Lymph as well as Immunology.
His work deals with themes such as Biomarker, Systemic lupus erythematosus, Nephrology and Kidney, which intersect with Lupus nephritis.
Between 2014 and 2021, his most popular works were:
- Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics (104 citations)
- Chd7 Cooperates with Sox10 and Regulates the Onset of CNS Myelination and Remyelination (80 citations)
- Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease (72 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Cancer
His scientific interests lie mostly in Immunology, Biopsy, Pathology, Cancer research and Biomarker.
His Immunology research integrates issues from Lung and Lymph.
His Biopsy study incorporates themes from Immunohistochemistry, Exome sequencing, Urology, Renal function and Glioma.
Pathology is frequently linked to Astrogliosis in his study.
The study incorporates disciplines such as Genotype-phenotype distinction, Haematopoiesis, Stem cell and Myelodysplastic syndromes in addition to Cancer research.
His Biomarker study necessitates a more in-depth grasp of Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
